Global Digital Therapeutics Market Size & Outlook
Global digital therapeutics market, 2018-2030 (US$M)
Related Markets
Global digital therapeutics market highlights
- The global digital therapeutics market generated a revenue of USD 6,222.1 million in 2023 and is expected to reach USD 32,516.6 million by 2030.
- The market is expected to grow at a CAGR (2024 - 2030) of 26.6% by 2030.
- In terms of segment, diabetes accounted for a revenue of USD 1,826.8 million in 2023.
- Diabetes is the most lucrative application segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2023.
- Country-wise, U.S. is expected to register the highest CAGR from 2024 to 2030.
Global data book summary
| Market revenue in 2023 | USD 6,222.1 million |
| Market revenue in 2030 | USD 32,516.6 million |
| Growth rate | 26.6% (CAGR from 2023 to 2030) |
| Largest segment | Diabetes |
| Fastest growing segment | Diabetes |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Diabetes, Obesity, CVD, Respiratory Diseases, Smoking Cessation, CNS Diseases |
Other key industry trends
- In terms of revenue, the North America accounted for 40.4% of the global digital therapeutics market in 2023.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, U.S. is the fastest growing regional market and is projected to reach USD 10,491.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Digital Therapeutics Market Scope
Digital Therapeutics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| DarioHealth Corp | View profile | 252 | 322 W. 57th Street, New York, NY, United States, 10011 | https://www.mydario.com |
| Omega Healthcare Investors Inc | View profile | 53 | 303 International Circle, Suite 200, Hunt Valley, MD, United States, 21030 | https://www.omegahealthcare.com |
| Hygeia Healthcare Holdings Co Ltd Ordinary Shares | View profile | 8238 | No. 228 Meiyuan Road, Enterprise Square, Suites 702-707, Jing’an District, Shanghai, China, People's Republic of | https://www.hygeia-group.com.cn |
| Mango Health | View profile | 11-50 | San Francisco, California, United States, North America | http://www.mangohealth.com |
| Akili Inc Ordinary Shares | View profile | 68 | 71 Commercial Street, Mailbox 312, Boston, MA, United States, 02109 | https://www.akiliinteractive.com |
| BioGaia AB Class B | View profile | 211 | Kungsbroplan 3A, Stockholm, Sweden, SE-112 27 | https://www.biogaia.se |
| Fitbit | View profile | 251-500 | San Francisco, California, United States, North America | http://www.fitbit.com |
| Teladoc Health Inc | View profile | 5600 | 2 Manhattanville Road, Suite 203, Purchase, NY, United States, 10577 | https://www.teladochealth.com |
| ResMed Inc | View profile | 10140 | 9001 Spectrum Center Boulevard, San Diego, CA, United States, 92123 | https://www.resmed.com |
Global digital therapeutics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to digital therapeutics market will help companies and investors design strategic landscapes.
Diabetes was the largest segment with a revenue share of 29.36% in 2024. Horizon Databook has segmented the Global digital therapeutics market based on diabetes, obesity, cvd, respiratory diseases, smoking cessation, cns diseases covering the revenue growth of each sub-segment from 2018 to 2030.
Growing regulatory initiatives are anticipated to propel standardization and R&D in the market over the forecast period. For instance, the Software Pre-Cert Pilot Program is part of the Digital Health Innovation Action Plan of the FDA intended for implying a more efficient governing oversight of software-based medical devices (SaMD) developed by manufacturers.
The program is aimed at developing an efficient regulatory oversight for assessing organizations to establish trust that they can develop high-quality Software-as-a-Medical-Device (SaMD) products. For instance, initiatives, such as the National Digital Health Mission (NDHM), are expected to accelerate the adoption rate of e-healthcare model in India.
Similarly, the &Innovation Strategy 2019-2021& implemented in UAE is driving digital transformation in the healthcare sector.In September 2020, the FDA released a status update for its Software Precertification Program. In this, the FDA specified that it has developed and tested components for the Pre-Cert model and will continue assessing how to integrate the components into a viable product lifecycle approach.
Reasons to subscribe to Global digital therapeutics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global digital therapeutics market databook
-
Our clientele includes a mix of digital therapeutics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global digital therapeutics market , including forecasts for subscribers. This global databook contains high-level insights into Global digital therapeutics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Global digital therapeutics market size, by regions, 2018-2030 (US$M)
Top 10 countries: Digital therapeutics market size, 2024 (US$M)
Global digital therapeutics market share, by application, 2024 & 2030 (%, US$M)
Digital therapeutics market: Opportunity assessment by country
Global digital therapeutics market, by region, 2024 (US$M)
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
